May 3, 2017 – On May 2, 2017, Mirage IP sued The Spectranetics Corporation, alleging that Defendant’s catheters, such as the AngioSculpX Drug-Coated
PCTA Scoring Balloon Catheter, infringes its U.S. Patent No. 6,958,059, entitled “Methods and Apparatuses for Drug Delivery to an Intravascular Occlusion.”
The case is captioned Mirage IP LLC v. The Spectranetics Corporation in the United States District Court for the Eastern District of Texas, TXED-2-17-cv-00382.
By: Joyce L. Nadipuram